After Reverse On Hydroxychloroquine Export Ban, India Says 'Only Meeting The Demand'
After President Trump complained, India reversed its export ban on the anti-malaria drug, which Trump has touted as a coronavirus treatment. There's no clinical evidence it works against COVID-19.
Under threat of "retaliation" from President Trump, India earlier this week reversed its export restrictions and some companies are ramping up production of a malaria drug Trump has touted as a potential game-changer for fighting COVID-19.
Medical experts including the National Institutes of Health's Dr. Anthony Fauci that there is no clinical evidence that hydroxychloroquine (HCQ) is an effective COVID-19 treatment. Clinical trials have only recently begun.
